Women being treated for breast cancer have to be especially careful that their treatment doesn’t lead to further health issues — particularly in regard to osteoporosis and bone loss. Studies have shown that women who are treated with aromatase inhibitors (AIs) face a higher risk of developing bone loss and osteoporosis, especially if these women are postmenopausal.
These findings have led to a host of medical associations — including the International Osteoporosis Foundation, the Cancer and Bone Society, and the International Society for Geriatric Oncology — to explore new treatment guidelines and any additional risk factors. The following are their updated recommendations for the prevention, assessment, and treatment of bone loss for breast cancer patients.
8. Doctors should assess your condition prior to beginning aromatase inhibitor treatment
A beginning physical to get an idea of your overall health is a must. This way, doctors will have a solid foundation for what course of action will work best for you as you undergo treatment, as well as what medications will be most appropriate.
7. Doctors should advise patients taking aromatase inhibitors on diet, exercise, and supplements
A healthy diet and regular exercise should help strengthen your bones and body. Doctors can help you target healthy foods for you to incorporate into your diet, as well as exercise activities that may be appropriate. They can also recommend whether you should take supplements, such as calcium and vitamin D, to help your body maintain healthy bones.
Click ‘next’ to read moreWhizzco